Cargando…

P522: OFF-THE-SHELF CD33 CAR-NK CELL THERAPY FOR RELAPSE/REFRACTORY AML: FIRST-IN-HUMAN, PHASE I TRIAL

Detalles Bibliográficos
Autores principales: Huang, Ruihao, Wen, Qin, Wang, Xiaoqi, Yan, Hongju, MA, Yingying, Wang, Maihong, Han, Xiao, Liu, Jia, Gao, LI, Gao, Lei, Zhang, Cheng, Zhang, XI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429699/
http://dx.doi.org/10.1097/01.HS9.0000968996.69938.df
_version_ 1785090777682018304
author Huang, Ruihao
Wen, Qin
Wang, Xiaoqi
Yan, Hongju
MA, Yingying
Wang, Maihong
Han, Xiao
Liu, Jia
Gao, LI
Gao, Lei
Zhang, Cheng
Zhang, XI
author_facet Huang, Ruihao
Wen, Qin
Wang, Xiaoqi
Yan, Hongju
MA, Yingying
Wang, Maihong
Han, Xiao
Liu, Jia
Gao, LI
Gao, Lei
Zhang, Cheng
Zhang, XI
author_sort Huang, Ruihao
collection PubMed
description
format Online
Article
Text
id pubmed-10429699
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104296992023-08-17 P522: OFF-THE-SHELF CD33 CAR-NK CELL THERAPY FOR RELAPSE/REFRACTORY AML: FIRST-IN-HUMAN, PHASE I TRIAL Huang, Ruihao Wen, Qin Wang, Xiaoqi Yan, Hongju MA, Yingying Wang, Maihong Han, Xiao Liu, Jia Gao, LI Gao, Lei Zhang, Cheng Zhang, XI Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429699/ http://dx.doi.org/10.1097/01.HS9.0000968996.69938.df Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Huang, Ruihao
Wen, Qin
Wang, Xiaoqi
Yan, Hongju
MA, Yingying
Wang, Maihong
Han, Xiao
Liu, Jia
Gao, LI
Gao, Lei
Zhang, Cheng
Zhang, XI
P522: OFF-THE-SHELF CD33 CAR-NK CELL THERAPY FOR RELAPSE/REFRACTORY AML: FIRST-IN-HUMAN, PHASE I TRIAL
title P522: OFF-THE-SHELF CD33 CAR-NK CELL THERAPY FOR RELAPSE/REFRACTORY AML: FIRST-IN-HUMAN, PHASE I TRIAL
title_full P522: OFF-THE-SHELF CD33 CAR-NK CELL THERAPY FOR RELAPSE/REFRACTORY AML: FIRST-IN-HUMAN, PHASE I TRIAL
title_fullStr P522: OFF-THE-SHELF CD33 CAR-NK CELL THERAPY FOR RELAPSE/REFRACTORY AML: FIRST-IN-HUMAN, PHASE I TRIAL
title_full_unstemmed P522: OFF-THE-SHELF CD33 CAR-NK CELL THERAPY FOR RELAPSE/REFRACTORY AML: FIRST-IN-HUMAN, PHASE I TRIAL
title_short P522: OFF-THE-SHELF CD33 CAR-NK CELL THERAPY FOR RELAPSE/REFRACTORY AML: FIRST-IN-HUMAN, PHASE I TRIAL
title_sort p522: off-the-shelf cd33 car-nk cell therapy for relapse/refractory aml: first-in-human, phase i trial
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429699/
http://dx.doi.org/10.1097/01.HS9.0000968996.69938.df
work_keys_str_mv AT huangruihao p522offtheshelfcd33carnkcelltherapyforrelapserefractoryamlfirstinhumanphaseitrial
AT wenqin p522offtheshelfcd33carnkcelltherapyforrelapserefractoryamlfirstinhumanphaseitrial
AT wangxiaoqi p522offtheshelfcd33carnkcelltherapyforrelapserefractoryamlfirstinhumanphaseitrial
AT yanhongju p522offtheshelfcd33carnkcelltherapyforrelapserefractoryamlfirstinhumanphaseitrial
AT mayingying p522offtheshelfcd33carnkcelltherapyforrelapserefractoryamlfirstinhumanphaseitrial
AT wangmaihong p522offtheshelfcd33carnkcelltherapyforrelapserefractoryamlfirstinhumanphaseitrial
AT hanxiao p522offtheshelfcd33carnkcelltherapyforrelapserefractoryamlfirstinhumanphaseitrial
AT liujia p522offtheshelfcd33carnkcelltherapyforrelapserefractoryamlfirstinhumanphaseitrial
AT gaoli p522offtheshelfcd33carnkcelltherapyforrelapserefractoryamlfirstinhumanphaseitrial
AT gaolei p522offtheshelfcd33carnkcelltherapyforrelapserefractoryamlfirstinhumanphaseitrial
AT zhangcheng p522offtheshelfcd33carnkcelltherapyforrelapserefractoryamlfirstinhumanphaseitrial
AT zhangxi p522offtheshelfcd33carnkcelltherapyforrelapserefractoryamlfirstinhumanphaseitrial